aTYR PHARMA INC Adjustments to Additional Paid in Capital, Warrant Issued
aTYR PHARMA INC (ATYR) reported Adjustments to Additional Paid in Capital, Warrant Issued of $263.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2020-03-26.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2020-03-26
- aTYR PHARMA INC adjustments to additional paid in capital, warrant issued for fiscal 2017 was $263.00K, a 21.20% increase from fiscal 2016.
- aTYR PHARMA INC adjustments to additional paid in capital, warrant issued for fiscal 2016 was $217.00K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|
| 2017-12-31 | $263.00K 10-K · filed 2020-03-26 |
| 2016-12-31 | $217.00K 10-K · filed 2019-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |